1. Home
  2. Institute
  3. Research Units
  4. Public Finance, Social Security, Distribution

Public Finance, Social Security, Distribution

Researchers in the competence area Public Finance, Social Security, Distribution study the fiscal effects of political measures.

Content element with id 1089

Download Overview

If we are to solve the challenges facing our society, such as public debt crisis and demographic change, first of all we need a sound theoretical and empirical analysis of public budgets and social insurance systems. Responding to this need, the researchers of the unit ‘Public Finance, Social Security Systems, Income and Wealth Distribution’ examine the fiscal consequences of specific government policies, analyse the incentive and distribution effects for companies and private households and evaluate governmental redistribution policies.

Our aim is to develop ideas for effective long-term financial policies and reliable and efficient social insurance coverage for the major risks in life, i.e. old age, illness and long- term care. In the European context this requires a profound analysis of the Member States’ regulatory framework in order to understand interdependencies between varying national subsystems.

Content element with id 9046

Sections of the Research Unit

Content element with id 3203
Content element with id 8992

Contact

View profile
Jochen Pimpertz

Dr. Jochen Pimpertz

Head of the Research Unit Public Finance, Social Security Systems, Income and Wealth Distribution

Tel: +49 221 4981-760
View profile
Martin Beznoska

Dr. Martin Beznoska

Senior Economist for Financial Policy and Tax Policy

Tel: +49 30 27877-101
View profile
Tobias Hentze

Dr. Tobias Hentze

Senior Economist for Financial Policy and Tax Policy

Tel: +49 221 4981-748
View profile
Björn Kauder

Dr. Björn Kauder

Senior Economist for Financial Policy and Tax Policy

Tel: +49 221 4981-516
View profile
Jasmina Kirchhoff

Dr. Jasmina Kirchhoff

Project Manager for Pharmaceutical Location Germany

Tel: +49 221 4981-813
View profile
Ruth Maria Schüler

Dr. Ruth Maria Schüler

Economist for social security systems and income and wealth distribution

Tel: +49 221 4981-885
View profile
Simon Schumacher

Simon Schumacher

Economist für Pharmastandort Deutschland

Tel: +49 221 4981-866
View profile
Maximilian Stockhausen

Dr. Maximilian Stockhausen

Economist for Income and Wealth Distribution

Tel: +49 30 27877 134
Content element with id 8746 Content element with id 8993

Studies and contributions

68 results
Read study
A Focus on the Middle Class - Demarcation, Development and Mobility
IW-Trends No. 2 16. May 2022

A Focus on the Middle Class - Demarcation, Development and Mobility

Judith Niehues / Maximilian Stockhausen

In 2018, roughly every second German was a member of the middle class as measured by income, a proportion which has barely changed for more than a decade. However, the lower income threshold of this middle-income group has risen - an indication of increased prosperity.

IW

Read study
Determinants and Normative Implications
IW-Trends No. 1 9. March 2022

Pension Concerns in Germany: Determinants and Normative Implications

Ruth Maria Schüler

The level of statutory pensions for future generations is set to decline systematically. If future retirees are to maintain their standard of living, they will therefore need to supplement their statutory benefits with private and occupational pensions – a change already initiated with the pension reforms of the early 2000s.

IW

Read study
An International Comparison
IW-Trends No. 1 9. February 2022

Where the German Pharmaceutical Industry Sources its Intermediate Inputs: An International Comparison

Jasmina Kirchhoff

The Corona pandemic has led to increasing demands for the reshoring of pharmaceutical production back to Germany. A strategic dependence on non-European active ingredient and drug manufacturers is cited as an argument.

IW

Read study
Disrupted Production, Price Rises and Pandemic Policies
IW-Trends No. 4 29. November 2021

IW Economic Forecast Winter 2021: Disrupted Production, Price Rises and Pandemic Policies

IW-Forschungsgruppe Gesamtwirtschaftliche Analysen und Konjunktur

In the course of 2021 Germany’s economic recovery has once again perceptibly lost momentum. After the strain brought about at the beginning of the year by the lockdown for the second and third waves of the Covid19 pandemic, manufacturing and construction companies are now struggling with a shortage of materials, while higher prices for fossil fuels are imposing an additional burden.

IW

Read study
Industry policy recommendations for a sustainable pharmaceutical industry
IW-Policy Paper No. 22 24. September 2021

More medicines "made in Germany" via international networking

Jasmina Kirchhoff

The Corona pandemic has put the German pharmaceutical industry more than ever in the focus of political and social discussions. At an unprecedented speed, pharmaceutical companies have developed and brought to market four vaccines approved in Europe – German companies have played a major role in this success.

IW

Content element with id 8880 Content element with id 9713